All Publications
-
Castaño D, Wang S, et al. IL-12 drives the differentiation of human T follicular regulatory cells. Sci. Immunol. 2024;9(97). doi: 10.1126/sciimmunol.adf2047
-
Lederer K, et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell. 2022; doi: 10.1016/j.cell.2022.01.027
-
Alameh MG, Tombácz I, Bettini E, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity. 2021; doi: 10.1016/j.immuni.2021.11.001
-
Lederer K, Castano D, Atria D, et al. SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity. 2020; doi: 10.1016/j.immuni.2020.11.009.
-
Laczkó D, Hogan MJ, Toulmin SA, et al. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020;S1074-7613(20)30326-5. doi:10.1016/j.immuni.2020.07.019
-
Carnathan DG, Kaushik K, Ellebedy AH, et al. Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers. Front Immunol. 2020;11:1213. doi:10.3389/fimmu.2020.01213
-
Schulten V, Tripple V, Seumois G, et al. Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells. J Allergy Clin Immunol. 2018;141(2):775-777.e6. doi:10.1016/j.jaci.2017.04.032
-
Wing JB, Kitagawa Y, Locci M, et al. A distinct subpopulation of CD25- T-follicular regulatory cells localizes in the germinal centers. Proc Natl Acad Sci U S A. 2017;114(31):E6400-E6409. doi:10.1073/pnas.1705551114
-
Havenar-Daughton C, Carnathan DG, Torrents de la Peña A, et al. Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer. Cell Rep. 2016;17(9):2195-2209. doi:10.1016/j.celrep.2016.10.085
-
Locci M, Wu JE, Arumemi F, et al. Activin A programs the differentiation of human TFH cells. Nat Immunol. 2016;17(8):976-984. doi:10.1038/ni.3494
-
Hu JK, Crampton JC, Locci M, Crotty S. CRISPR-Mediated Slamf1Δ/Δ Slamf5Δ/Δ Slamf6Δ/Δ Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects. PLoS One. 2016;11(5):e0156074. doi:10.1371/journal.pone.0156074
-
Cubas R, van Grevenynghe J, Wills S, et al. Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection. J Immunol. 2015;195(12):5625-5636. doi:10.4049/jimmunol.1501524
-
Locci M, Havenar-Daughton C, Landais E, et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity. 2013;39(4):758-769. doi:10.1016/j.immuni.2013.08.031
-
Kageyama R, Cannons JL, Zhao F, et al. The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development. Immunity. 2012;36(6):986-1002. doi:10.1016/j.immuni.2012.05.016
-
Kroenke MA, Eto D, Locci M, et al. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol. 2012;188(8):3734-3744. doi:10.4049/jimmunol.1103246
-
Bosticardo M, Draghici E, Schena F, et al. Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2011;127(6):1376-84.e5. doi:10.1016/j.jaci.2011.03.030
-
Marangoni F, Bosticardo M, Charrier S, et al. Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models". Mol Ther. 2009;17(7):1300. doi:10.1038/mt.2009.61
-
Marangoni F, Bosticardo M, Charrier S, et al. Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol Ther. 2009;17(6):1073-1082. doi:10.1038/mt.2009.31
-
Locci M, Draghici E, Marangoni F, et al. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med. 2009;206(4):735-742. doi:10.1084/jem.20081773